Related Experiment Video
Updated: May 21, 2026
09:47
Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
Published on: February 19, 2016
Colloidal systems for drug delivery: from design to therapy
Mariana Beija1, Robert Salvayre, Nancy Lauth-de Viguerie
1Australian Centre For NanoMedicine (ACN), School of Chemical Engineering, The University of New South Wales, Sydney, NSW 2052, Australia. m.beija@unsw.edu.au
Trends in Biotechnology
|June 8, 2012
Summary
Nanomedicine utilizes nanometric devices to improve drug delivery, overcoming limitations of traditional drugs by enhancing biodistribution and reducing side effects. This review explores various colloidal nanovectors for disease treatment.
Area of Science:
- Nanomedicine and Drug Delivery
- Biotechnology and Biomedical Engineering
Background:
- Traditional drugs often exhibit poor biodistribution, leading to limited therapeutic efficacy and increased side effects.
- Nanomedicine offers solutions by employing nanometric devices to improve drug delivery and targeting.
Purpose of the Study:
- To provide an overview of colloidal nanovectors used in nanomedicine.
- To discuss the characteristics, advantages, and disadvantages of various nanovectors.
- To explore the application of nanovectors in disease treatment.
Main Methods:
- Review of existing literature on colloidal nanovectors.
- Analysis of nanovector characteristics, including liposomes, polymeric micelles, vesicles, nanoparticles (NPs), and dendrimers.
Main Results:
- Nanovectors can modify drug biodistribution, enhancing therapeutic efficacy and minimizing side effects.
- Different nanovectors possess unique properties suitable for various therapeutic applications.
Conclusions:
- Colloidal nanovectors represent a promising approach in nanomedicine for improved drug delivery.
- Further research into nanovector characteristics and applications can optimize disease treatment strategies.
Related Concept Videos
01:24Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
01:23Oral Drug Delivery Systems: Introduction
Oral drug delivery is the most common route of administration due to its convenience, cost-effectiveness, and high patient compliance. It enables precise formulation to ensure proper drug dosage and bioavailability. The development of oral dosage forms considers drug properties such as solubility, stability, and absorption to optimize therapeutic efficacy.Tablets, capsules, liquids, and chewable formulations enhance drug stability, mask undesirable tastes, and improve patient experience.
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...